Olympus New Zealand selected as a finalist for James & Wells 2017 MTANZ Innovation Awards
Erin Currie, Olympus New Zealand Business Manager, receives the finalist award at the 2017 James & Wells MTANZ Innovation Awards
Olympus New Zealand is proud to have been recognised as a finalist at this year’s James & Wells Medical Technology Association of New Zealand (MTANZ) Innovation Awards for the ShockPulse-SE Lithrotripsy System. The ShockPulse-SE, introduced to the New Zealand market in 2016, is the world’s only Dual Action Lithotripsy System with surgeon control and continues to be at the leading edge of technology.
The MTANZ recognises innovative industry excellence via it’s prestigious and annually held MTANZ Innovation Award.
Erin Currie, New Zealand Business Manager was delighted with the recognition.
“At Olympus we are focused on improving people’s lives, every day, via innovation. As a precision technology leader, we design and deliver innovative solutions in our core business areas.”
“Given this philosophy, we feel genuinely honoured to see the ShockPulse-SE recognised by the MTANZ, it’s truly an example of Olympus product innovation targeted at improving the lives of both its clinical userbase and more importantly, the everyday lives of patients that are treated with the device.”
The MTANZ is the only industry body representing medical technology manufacturers, importers, exporters and distributors of medical devices in New Zealand.
The James & Wells 2017 MTANZ Innovation Awards presentation ceremony was held on June 19th, 2017.